Published in
American Society of Hematology, Blood Advances, 15(1), p. 1056-1066, 2017
DOI: 10.1182/bloodadvances.2017005447
Links
Tools
Immune signatures associated with improved progression-free and overall survival for myeloma patients treated with AHSCT
Journal article published in 2017 by
Christine M. Ho,
Philip L. McCarthy 
,
Paul K. Wallace,
Yali Zhang,
Ahmad Fora,
Patrick Mellors,
Joseph D. Tario,
Benjamin L. S. McCarthy,
George L. Chen,
Sarah A. Holstein,
Sophia R. Balderman,
Xuefang Cao,
Bruno Paiva ,
Theresa Hahn
,
Paul K. Wallace,
Yali Zhang,
Ahmad Fora,
Patrick Mellors,
Joseph D. Tario,
Benjamin L. S. McCarthy,
George L. Chen,
Sarah A. Holstein,
Sophia R. Balderman,
Xuefang Cao,
Bruno Paiva ,
Theresa Hahn
This paper is made freely available by the publisher.
Full text: Download
Preprint: archiving forbidden
Postprint:
archiving forbidden
Data provided by 
Abstract
Key Points Specific immune phenotypes were predictive of long-term survival for MM patients undergoing transplantation. MRD status and use of maintenance therapy were associated with unique immune profiles predictive of outcome.